FORT COLLINS – A Colorado State University-led study of U.S. patents involving human genes indicates the recent U.S. Supreme Court ruling that the genes cannot be patented by companies will likely have less impact than originally anticipated. 

The Supreme Court ruled unanimously Thursday that human genes cannot be patented, a decision that could shape the future of medical and genetic research and have profound effects on pharmaceuticals and agriculture. 

Clovis Oncology, Inc. (Nasdaq: CLVS), announced today the addition of two new members to its Board of Directors, Ginger Graham and Keith Flaherty, M.D.  

WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) today released a new white paper recommending that current FDA guidance for determining when to submit a 510(k) for a change to a currently marketed medical device be maintained with some targeted modifications, arguing the current process works well to ensure the safety and effectiveness of devices. 

Denver (June 12, 2013) - The College of American Pathologists (CAP) has renewed CAP 15189SM Accreditation for National Jewish Health Advanced Diagnostic Laboratories. Currently, only 22 laboratories in the United States have earned this prestigious accreditation. 

Surgeons in Europe have completed clinical trials on the world’s first serviceable bioprosthetic heart valve, paving the way for the CE mark and commercial sale of an advanced heart valve that eliminates many common problems for cardiac valve patients. 

Christopher J. Morl, M.B.A., B.Sc. (Hons), Joins as Chief Business Officer 

Siva Therapeutics (Boulder) hosted an open house at their new facility June 7th and demonstrated the use of SivaRods, gold nanorods that are designed to absorb I.R. light and emit heat to destroy cancerous tumors. 

Medtronic Neurosurgery, headquartered in Louisville, CO, is part of the Medtronic Surgical Technologies division headquartered in Jacksonville, FL. Just in the U.S., the business unit employs 2400 employees in several states (and 3000 worldwide).  Medtronic Neurosurgery is celebrating the 500th O-arm® imaging system installation globally and the 4000th StealthStation® surgical navigation system installation.  This is a significant clinical milestone in the relatively new arena of intra-operative imaging and surgical navigation.  Together the O arm imaging system and StealthStation® navigation system have enhanced spinal surgery around the globe. There are now more than 1,000 surgeon users and more than 191,000 patients who have been treated by this solution. In addition, the technologies can be found in 39 countries to serve many patient populations.  

BOULDER, CO, June 10, 2013 – AmideBio, LLC, a privately held biopharmaceutical company which has developed novel manufacturing processes for peptides and proteins and has under development novel Thermostable Insulin, announced today that Dr. Gilad Gordon has joined its Scientific  Advisory Board. Professor Gordon brings over 20 years of scientific expertise in Private Industry and Academia, including his current position as a Clinical Associate Professor of Medicine at the University of Colorado Health Sciences Center and Principal at the ORRA Medical Consulting Group, which provides expertise in the development and implementation of Clinical trial programs in the biotechnology and pharmaceutical industry.